Physician profile
John A Maslin
NPI 1730797523
$1,518.07
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,162 · 2022: $356.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fresenius USA Marketing, INC. | $296.64 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $271.93 | 2021 | |
| Mallinckrodt Hospital Products INC. | $139.56 | 2021-2022 | |
| Ani Pharmaceuticals, INC. | $127.35 | 2022 | |
| Daiichi Sankyo INC. | $98.75 | 2021 | |
| Vifor Pharma, INC. | $95.85 | 2021-2022 | |
| Novo Nordisk INC | $94.76 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $82.59 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $74.68 | 2021-2022 | |
| Amgen INC. | $62.92 | 2021 | |
| Opko Pharmaceuticals, LLC | $50.16 | 2021-2022 | |
| Akebia Therapeutics INC | $39.27 | 2021-2022 | |
| Pharmacosmos Therapeutics INC. | $26.19 | 2021 | |
| Alexion Pharmaceuticals, INC. | $21.40 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $20.32 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aurinia Pharma U.S., INC. | $15.70 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Maslin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.